News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
352,370 Results
Type
Article (17556)
Company Profile (79)
Press Release (334735)
Multimedia
Podcasts (198)
Webinars (7)
Section
Business (94336)
Career Advice (528)
Deals (15393)
Drug Delivery (72)
Drug Development (35756)
Employer Resources (48)
FDA (10773)
Job Trends (7156)
News (159158)
Policy (14799)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
Academia (1612)
Accelerated approval (12)
Adcomms (11)
Allergies (77)
Alliances (28857)
ALS (92)
Alzheimer's disease (1063)
Antibody-drug conjugate (ADC) (142)
Approvals (11031)
Artificial intelligence (387)
Autoimmune disease (107)
Automation (32)
Bankruptcy (106)
Best Places to Work (6293)
BIOSECURE Act (8)
Biosimilars (78)
Biotechnology (54)
Bladder cancer (97)
Brain cancer (39)
Breast cancer (386)
Cancer (2931)
Cardiovascular disease (186)
Career advice (451)
Career pathing (12)
CAR-T (163)
CDC (15)
Celiac Disease (2)
Cell therapy (427)
Cervical cancer (19)
Clinical research (30678)
Collaboration (991)
Compensation (225)
Complete response letters (18)
COVID-19 (1462)
CRISPR (62)
C-suite (368)
Cystic fibrosis (58)
Data (3565)
Decentralized trials (2)
Denatured (73)
Depression (77)
Diabetes (260)
Diagnostics (6556)
Digital health (33)
Diversity (9)
Diversity, equity & inclusion (14)
Drug discovery (134)
Drug pricing (82)
Drug shortages (8)
Duchenne muscular dystrophy (69)
Earnings (36148)
Editorial (17)
Employer branding (2)
Employer resources (45)
Events (49121)
Executive appointments (443)
FDA (12729)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (11)
Funding (753)
Gene editing (123)
Generative AI (30)
Gene therapy (322)
GLP-1 (329)
Government (2229)
Grass and pollen (2)
Guidances (231)
Healthcare (10702)
HIV (26)
Huntington's disease (16)
IgA nephropathy (41)
Immunology and inflammation (124)
Immuno-oncology (28)
Indications (62)
Infectious disease (1598)
Inflammatory bowel disease (89)
Inflation Reduction Act (9)
Influenza (58)
Intellectual property (133)
Interviews (61)
IPO (6620)
IRA (22)
Job creations (1096)
Job search strategy (393)
JPM (27)
Kidney cancer (12)
Labor market (9)
Layoffs (137)
Leadership (7)
Legal (2465)
Liver cancer (57)
Longevity (9)
Lung cancer (397)
Lymphoma (254)
Machine learning (27)
Management (18)
Manufacturing (421)
MASH (94)
Medical device (10561)
Medtech (10599)
Mergers & acquisitions (9345)
Metabolic disorders (568)
Multiple sclerosis (121)
NASH (10)
Neurodegenerative disease (186)
Neuropsychiatric disorders (42)
Neuroscience (1773)
Neurotech (1)
NextGen: Class of 2026 (3270)
Non-profit (1955)
Now hiring (14)
Obesity (198)
Opinion (125)
Ovarian cancer (99)
Pain (119)
Pancreatic cancer (138)
Parkinson's disease (139)
Partnered (17)
Patents (289)
Patient recruitment (254)
Peanut (41)
People (26894)
Pharmaceutical (15)
Pharmacy benefit managers (17)
Phase 1 (9734)
Phase 2 (13220)
Phase 3 (10361)
Pipeline (2887)
Policy (125)
Postmarket research (1034)
Preclinical (4221)
Press Release (30)
Prostate cancer (152)
Psychedelics (20)
Radiopharmaceuticals (181)
Rare diseases (396)
Real estate (2451)
Recruiting (21)
Regulatory (12552)
Reports (22)
Research institute (1508)
Resumes & cover letters (97)
Rett syndrome (24)
RNA editing (8)
RSV (39)
Schizophrenia (81)
Series A (122)
Series B (99)
Service/supplier (7)
Sickle cell disease (42)
Special edition (4)
Spinal muscular atrophy (67)
Sponsored (30)
Startups (1810)
State (1)
Stomach cancer (8)
Supply chain (47)
Tariffs (21)
The Weekly (123)
Vaccines (487)
Venture capital (40)
Weight loss (112)
Women's health (64)
Worklife (2)
Date
Last 7 days (304)
Last 30 days (1074)
Last 365 days (15269)
2026 (1456)
2025 (15552)
2024 (18393)
2023 (21296)
2022 (28569)
2021 (30096)
2020 (29083)
2019 (23907)
2018 (17956)
2017 (17059)
2016 (16284)
2015 (18719)
2014 (13741)
2013 (11656)
2012 (12736)
2011 (13109)
2010 (11509)
Location
Africa (352)
Alabama (28)
Alaska (3)
Arizona (194)
Arkansas (12)
Asia (19309)
Australia (3320)
California (5252)
Canada (1369)
China (550)
Colorado (308)
Connecticut (273)
Delaware (176)
Europe (46230)
Florida (952)
Georgia (205)
Hawaii (1)
Idaho (30)
Illinois (437)
India (43)
Indiana (309)
Iowa (18)
Japan (244)
Kansas (70)
Kentucky (22)
Louisiana (16)
Maine (35)
Maryland (686)
Massachusetts (3698)
Michigan (187)
Minnesota (414)
Mississippi (4)
Missouri (100)
Montana (28)
Nebraska (18)
Nevada (63)
New Hampshire (59)
New Jersey (1626)
New Mexico (29)
New York (1706)
North Carolina (702)
North Dakota (8)
Northern California (2553)
Ohio (193)
Oklahoma (10)
Oregon (25)
Pennsylvania (914)
Puerto Rico (11)
Rhode Island (25)
South America (464)
South Carolina (37)
South Dakota (1)
Southern California (1999)
Tennessee (102)
Texas (1038)
United States (20314)
Utah (282)
Vermont (1)
Virginia (163)
Washington D.C. (26)
Washington State (479)
West Virginia (3)
Wisconsin (80)
Wyoming (2)
352,370 Results for "bd diagnostic systems".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Waters Shareholders Approve Combination with BD’s Biosciences & Diagnostic Solutions Business
January 28, 2026
·
9 min read
Press Releases
BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business
January 28, 2026
·
11 min read
Press Releases
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26
January 28, 2026
·
2 min read
Press Releases
BD to Announce Financial Results for its First Quarter of Fiscal 2026
January 28, 2026
·
2 min read
Press Releases
BD To Host Virtual 2026 Annual Meeting of Shareholders
January 13, 2026
·
2 min read
Press Releases
BD Announces CFO Transition Plan
October 16, 2025
·
16 min read
Press Releases
BD Board Increases Dividend for 54th Consecutive Year
November 6, 2025
·
2 min read
Press Releases
BD Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
November 6, 2025
·
44 min read
Press Releases
Waters and BD’s Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing
July 14, 2025
·
23 min read
Gene therapy
Lilly Doubles Down on Eye Diseases, Adding to BD Spree
MeiraGTx Holdings is licensing a genetic eye disease medicine to Eli Lilly in a deal worth up to $475 million.
November 10, 2025
·
1 min read
·
Annalee Armstrong
1 of 35,237
Next
